Study guide

18.1 Arterial & Venous Hemostasis

Registered Cardiovascular Invasive Specialist RCIS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current RCIS Exam Facts 1.2 Eligibility Pathways & Documentation 1.3 Examination Matrix & Study Plan

2 Pre-Procedural Room Setup & Sterile Technique

2.1 Procedure & Control Room Setup 2.2 Sterile Technique & Universal Precautions 2.3 Personnel Preparation & Cath Lab Roles

3 Pre-Procedural Patient Preparation & Validation

3.1 Preparing the Patient for Invasive Procedures 3.2 Records, Labs, Allergies & Consent 3.3 Time-Out & Universal Protocol

4 Patient Monitoring & Vascular Access

4.1 Intraprocedural Vital Sign Monitoring 4.2 Arterial & Venous Access Sites 4.3 Ultrasound-Guided Access

5 Coronary Anatomy & Left Heart Catheterization

5.1 Coronary Anatomy & Dominance 5.2 Left Heart Catheterization & Coronary Angiography 5.3 Catheter Shapes & Angiographic Projections 5.4 Left Ventriculography & Aortography

6 Right Heart Catheterization & Hemodynamics

6.1 Right Heart Waveforms & Pressures 6.2 Cardiac Output: Fick & Thermodilution 6.3 Valve Area, Bernoulli & Shunt Calculations 6.4 Endomyocardial Biopsy Support

7 ECG & Intracardiac/Intravascular Imaging

7.1 12-Lead ECG in the Cath Lab 7.2 Intracardiac Echocardiography (ICE) 7.3 IVUS & OCT 7.4 Identifying Structures on Cardiac Ultrasound

8 Physiology Assessment & Radiation Safety

8.1 FFR & iFR Studies 8.2 Radiation Safety & ALARA 8.3 Radiographic Equipment Operation 8.4 Image Acquisition & Interpretation

9 Cath Lab Pharmacology

9.1 Anticipating Pharmacologic Needs 9.2 Recognizing Medication Effects & Adverse Reactions 9.3 Anticoagulation & ACT Targets

10 PCI Fundamentals

10.1 Balloon Angioplasty & Stent Platforms 10.2 Coronary Wiring, Lesion Prep & Flow Grades 10.3 Vascular Closure Devices

11 Chapter 11: Complex Coronary Intervention

11.1 CTO, Atherectomy & Alcohol Septal Ablation 11.2 Cardiac Thrombectomy (Mechanical & Aspiration) 11.3 Distal Protection Devices

12 Device Implants & Temporary Support

12.1 Pacemaker, ICD, CRT & Loop Recorders 12.2 Transvenous Temporary Pacemaker 12.3 Pericardiocentesis Support

13 Mechanical Circulatory Support

13.1 IABP & Impella 13.2 ECMO & LVAD Overview for the Cath Lab

14 Peripheral Vascular Interventions

14.1 Peripheral Interventions 14.2 Complex Peripheral Interventions 14.3 Peripheral Thrombectomy & Thrombolysis

15 Structural Heart Interventions

15.1 Nonvalvular Structural Therapies 15.2 Percutaneous Valve Interventions

16 Chapter 16: Emergency Clinical Presentations & Equipment

16.1 STEMI, Cardiogenic Shock & Pulmonary Edema 16.2 Stroke & Neurologic Emergencies in the Lab 16.3 Emergency Equipment Operation

17 Intraprocedural Complications

17.1 Coronary Interventional Complications 17.2 Peripheral & Structural Complications

18 Post-Procedural Activities

18.1 Arterial & Venous Hemostasis 18.2 Access-Site Complications 18.3 Patient Education, Reporting & Transfer of Care

18.1 Arterial & Venous Hemostasis

Key Takeaways Explain This Topic AI

Sheath removal timing depends on anticoagulation status — ACT ≤150–180 seconds, therapeutic heparin reversed or elapsed per protocol, and stable hemodynamics are typical prerequisites before arterial hemostasis.

Transradial patent hemostasis maintains antegrade flow while achieving hemostasis, reducing radial artery occlusion (RAO) compared with complete radial artery compression.

Femoral hemostasis uses manual compression (15–20+ minutes for 5–6 Fr), mechanical assist devices, or suture/clip/nitinol closure devices — each with distinct post-care and complication profiles.

Venous sheath removal requires less aggressive hemostasis than arterial sites; pressure is applied until hemostasis is achieved without compromising distal perfusion or creating deep venous thrombosis risk.

The RCIS monitors distal perfusion (pulse oximetry on the hand, pedal pulses), assesses hematoma formation, documents hemostasis method and time, and escalates when compression fails or bleeding recurs.

Last updated: July 2026

Hemostasis as a Core RCIS Competency

Post-procedural hemostasis is Domain E Task 1 on the CCI RCIS Detailed Test Outline. After diagnostic or interventional catheterization, the RCIS participates in sheath removal , compression or closure device deployment , distal perfusion monitoring , and documentation of the hemostasis method. Hemostasis is not a passive waiting period — it is active surveillance for rebleeding, hematoma expansion, limb ischemia, and closure-device failure while balancing the competing goals of achieving hemostasis and preserving vessel patency .

Every hemostasis plan begins with three questions answered before sheath pull: Is anticoagulation adequate for hemostasis? Is the patient hemodynamically stable? Which site-specific technique does institutional protocol require? The RCIS communicates these answers to the operator and nursing team before proceeding.

  • Pre–Sheath Removal Assessment
  • Anticoagulation Status

Most cath lab cases involve unfractionated heparin with ACT (activated clotting time) monitoring. Typical sheath-removal thresholds:

  • Parameter Common Threshold for Sheath Pull Clinical Notes
  • ACT ≤150–180 seconds Institution-specific; lower for closure devices
  • aPTT Near baseline if heparin given Used when ACT unavailable
  • Bivalirudin Per protocol (often 1–2 hr post-procedure) Shorter half-life than heparin
  • GPI (abciximab, eptifibatide, tirofiban) Per drug half-life and bleeding risk May delay femoral hemostasis

If ACT remains elevated, options include waiting , protamine reversal (heparin-specific, per physician order with allergy assessment), or continued sheath dwell with immobilization. The RCIS does not independently order reversal agents — scope is measure, report, and assist.

Hemodynamic Stability

Sheath removal during active hypotension , ongoing bleeding , or unstable arrhythmia increases risk. Confirm stable blood pressure , no active groin or wrist bleed , and adequate distal perfusion before proceeding. For femoral large-bore cases (TAVR, Impella, ECMO), the team may remove sheaths in the lab with surgical backup available.

Distal Perfusion Baseline

Before arterial sheath pull, document baseline distal perfusion : radial access — pulse oximetry plethysmography on the thumb , capillary refill, hand temperature; femoral access — dorsalis pedis and posterior tibial pulses (Doppler if non-palpable), foot color and temperature. Post-hemostasis monitoring compares against this baseline every 15 minutes (or per protocol) for the first hour.

Transradial Arterial Hemostasis

Transradial patent hemostasis is the standard of care for radial sheath removal. Unlike complete radial compression (which occludes antegrade flow and increases radial artery occlusion [RAO] rates of 5–10%), patent hemostasis maintains forward flow through the radial artery while achieving surface hemostasis at the puncture site.

Patent Hemostasis Technique

Connect a hemostatic wrist device (TR Band, Vasc Band, or equivalent) to a pulse oximetry probe on the thumb .

Remove the sheath while applying minimal surface pressure .

Inflate the device just enough to achieve hemostasis — confirmed by absence of bleeding AND visible plethysmography waveform on the thumb oximeter.

If the waveform disappears, slightly deflate until flow returns; if bleeding persists, incrementally inflate .

Gradual deflation per device protocol (typically over 1–2 hours ) with waveform monitoring throughout.

  • Patent Hemostasis Goal How to Verify Failure Sign
  • Surface hemostasis No active bleeding at skin entry Soaking through dressing
  • Antegrade flow Thumb SpO2 plethysmography waveform present Flat waveform = over-compression
  • Patient comfort No hand numbness or severe pain Paresthesias, pallor, cold hand

RAO is usually asymptomatic but eliminates future radial access in that artery. Risk factors include small artery diameter , multiple punctures , inadequate procedural anticoagulation , and prolonged complete compression . Patent hemostasis, 6–7 Fr or smaller sheaths , and adequate heparinization during the case reduce RAO incidence.

Manual Radial Compression

When a patent hemostasis device is unavailable, direct manual pressure at the puncture site for 10–20 minutes followed by a pressure dressing is acceptable. Avoid complete radial artery compression across the wrist — use point pressure over the arteriotomy only.

Transfemoral Arterial Hemostasis

Femoral hemostasis strategy depends on sheath size , anticoagulation , and operator preference .

Manual Compression

Manual compression remains the reference standard. For a 5–6 Fr sheath , typical compression duration is 15–20 minutes of firm, direct pressure over the common femoral artery puncture site (not the vein, not the surrounding tissue). Larger sheaths require longer compression (20–30+ minutes for 8 Fr, proportionally longer for large-bore). The RCIS or trained team member applies pressure with two hands stacked or a mechanical compression assist device (FemoStop, Clo-Sur, etc.) while monitoring the patient.

Critical technique points:

Pressure is applied 1–2 cm above the skin entry (the arteriotomy lies cephalad to the skin nick).

The leg remains straight and immobilized.

After initial hold, apply a sandbag or pressure device and monitor for hematoma , bruit , and distal pulse loss .

Closure Devices

Suture-mediated closure (Perclose ProGlide, Prostar) deploys stitches across the arteriotomy. Collagen plug devices (Angio-Seal) create an anchor inside and outside the artery. Sealant/gel devices (Mynx, Mynx Control) deliver an extravascular sealant. Nitinol clip devices (StarClose, Catalyst) clip the arteriotomy.

  • Device Category Mechanism RCIS Role Post-Care Notes
  • Suture-mediated Perclose stitch Assist deployment, confirm hemostasis Bed rest per protocol; avoid hip flexion
  • Collagen plug Angio-Seal anchor Assist, verify deployment angiography Avoid leg crossing; device resorbs
  • Sealant/gel Mynx extravascular seal Assist, confirm no active bleed Shorter bed rest than some suture devices
  • Nitinol clip StarClose clip Assist deployment Follow manufacturer bed-rest guidance

Closure devices allow earlier ambulation and shorter manual compression but carry device-specific complications: infection , delayed bleeding after early ambulation , leg ischemia from suture entrapment , and failure requiring surgical repair . The RCIS documents device type, size, and deployment success in the procedural record.

Brachial and Other Arterial Sites

Brachial artery hemostasis requires firm, directed pressure for 15–20 minutes without compressing the median nerve (located medial to the brachial artery). Monitor hand perfusion (capillary refill, thumb pulse oximetry) because brachial collateral circulation is limited compared with the radial-ulnar arch.

Ulnar artery access (rare) follows radial patent hemostasis principles with monitoring on the fifth digit plethysmography.

Venous Hemostasis

Venous sheath removal (IJ, femoral vein, antecubital vein) requires less compression force than arterial sites because venous pressure is lower. Apply direct pressure for 5–10 minutes until hemostasis is achieved, then a pressure dressing . Avoid excessive compression that creates venous stasis or thrombosis .

For IJ sheath removal , have the patient perform a Valsalva maneuver during removal (reduces air embolism risk), apply pressure at the puncture site, and observe for neck hematoma , airway compromise , or voice changes suggesting expanding hematoma.

Troubleshooting Failed Hemostasis

  • Situation Immediate RCIS Actions
  • Rebleed after initial hemostasis Reapply firm pressure; notify operator; check BP and ACT
  • Expanding groin hematoma Hold pressure; obtain hemoglobin; prepare ultrasound/surgical consult
  • Loss of distal pulse Release compression partially; notify operator immediately
  • Patient reports back/flank pain post-femoral Consider retroperitoneal bleed; notify team; stat hemoglobin
  • Documentation Requirements

Document in the procedural record:

  • Sheath size and removal time
  • ACT or coagulation status at removal
  • Hemostasis method (manual, device type, patent hemostasis band)
  • Distal perfusion check before and after
  • Complications or re-bleeding events
  • Exam Focus Points

High-yield RCIS scenarios include patent hemostasis with plethysmography waveform monitoring , ACT thresholds before sheath pull , femoral compression duration by sheath size , closure device bed-rest restrictions , and differentiating over-compression (flat plethysmography) from adequate patent hemostasis . Wrong answers often suggest complete radial artery occlusion is acceptable , venous and arterial hemostasis require identical pressure duration , or sheath removal proceeds despite ACT >250 without reversal plan .